期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 92, 期 4, 页码 446-449出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2012.117
关键词
-
资金
- National Institutes of Health [K12 CA139160]
- Conquer Cancer Foundation of the American Society for Clinical Oncology
- William F.O'Connor Foundation
The paradigm of individualized drug therapy based on genetics is an ideal that is now potentially possible. However, translation of pharmacogenomics into practice has encountered barriers such as limited availability and the high cost of genetic testing, the delays involved, disagreements about interpretation of results, and even lack of understanding about pharmacogenomics in general. We describe our institutional pharmacogenomics-implementation project, The 1200 Patients Project, a model designed to overcome these barriers and facilitate the availability of pharmacogenomic information for personalized prescribing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据